Company information lookup

PSIVIDA CORP. (PVA)

The Company is the successor entity to pSivida Limited (ASX code: PVA), an ASX listed pharmaceutical and biotechnology development company which undertook a restructure by way of scheme of arrangement resulting in it becoming a wholly owned subsidiary of the Company, thereby re-domiciling to the USA.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PVA 3.040 1.33% 2.810 3.090 3.000 3.040 3.000 380

ASX Find a broker tool

Helps you find an ASX broker based on your needs and where you live.

PSIVIDA CORP. details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PVA
Securities
Official Listing Date 12 June, 2008
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.psivida.com
Registered Office Address c/- Blake Dawson, Level 37, 101 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (08) 9227 8327
Head Office Fax (08) 9227 6838
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Dr David Mazzo (Non Exec. Chairman)
Dr Paul Ashton (President, Managing Director, CEO)
Mr Douglas Godshall (Director)
Mr Paul Hopper (Director)
Mr Michael Rogers (Director)
Mr Peter Savas (Director)
Mr Len Ross (Finance Director)
Ms Lori Freedman (General Counsel)
Mr Brian Leedman (Investor Relations)
Mr Charles Baird (Local Agent)
Company Secretary Ms Lori Freedman
Principal Activities The Company is the successor entity to pSivida Limited (ASX code: PVA), an ASX listed pharmaceutical and biotechnology development company which undertook a restructure by way of scheme of arrangement resulting in it becoming a wholly owned subsidiary of the Company, thereby re-domiciling to the USA.

PSIVIDA CORP. announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
15/05/2013   Form 10-Q 29 PDF
14/05/2013 asterix pSivida Corp. third quarter fiscal year 2013 results 5 PDF
08/05/2013 asterix pSivida's Iluvien launches in Germany- first patient treated 2 PDF
07/05/2013   pSivida announces third qtr financial results release date 1 PDF
02/05/2013   Appendix 3B 13 PDF
02/05/2013 asterix pSivida Announces New ILUVIEN PDUFA Date of October 17, 2013 3 PDF
30/04/2013 asterix pSivida reports that Iluvien is now available in the UK 3 PDF
11/04/2013   pSivida launches new online corporate communications channel 2 PDF
05/04/2013 asterix pSivida announces new evaluation agreement with large Pharma 2 PDF
02/04/2013   Appendix 3B 13 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 May 2013 3.040 1.33% 3.040 3.000 380
23 May 2013 3.000 2.74% 3.000 2.950 12,450
22 May 2013 2.920 2.46% 2.920 2.920 6,300
21 May 2013 2.850 -1.04% 2.880 2.850 3,792
20 May 2013 2.880 -7.1% 2.880 2.880 3,303

* Volume of shares shown represents only those shares traded on ASX.

PSIVIDA CORP. price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PVA. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PVA

Warrants & Structured Products

No warrants & Structured Products are available over the security PVA

ASX CFDs

No Contracts For Differences are available over the security PVA